MoneyWorks4Me

A fair growth of 18.23% in the revenue at Rs. 10288.13 millions was reported in the December 2024 quarter as compared to Rs. 8701.57 millions during year-ago period.Net profit for the quarter ended December 2024 increases to Rs. 502.04  millions from Rs. 482.57 millions.A decline of 1438.27 millions was observed in the OP in the quarter ended December 2024 from 1570.09 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 10288.13 8701.57 18.23 10288.13 8701.57 18.23 10288.13 8701.57 18.23
Other Income 194.10 251.88 -22.94 194.10 251.88 -22.94 194.10 251.88 -22.94
PBIDT 1438.27 1570.09 -8.40 1438.27 1570.09 -8.40 1438.27 1570.09 -8.40
Interest 199.29 420.34 -52.59 199.29 420.34 -52.59 199.29 420.34 -52.59
PBDT 1238.98 1149.75 7.76 1238.98 1149.75 7.76 1238.98 1149.75 7.76
Depreciation 566.46 543.42 4.24 566.46 543.42 4.24 566.46 543.42 4.24
PBT 672.52 606.33 10.92 672.52 606.33 10.92 672.52 606.33 10.92
TAX 170.48 123.76 37.75 170.48 123.76 37.75 170.48 123.76 37.75
Deferred Tax 105.19 6.79 1449.19 105.19 6.79 1449.19 105.19 6.79 1449.19
PAT 502.04 482.57 4.03 502.04 482.57 4.03 502.04 482.57 4.03
Equity 1894.32 1808.52 4.74 1894.32 1808.52 4.74 1894.32 1808.52 4.74
PBIDTM(%) 13.98 18.04 -22.52 13.98 18.04 -22.52 13.98 18.04 -22.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..